British Business Bank backs EQT Life Sciences with €25M commitment

EQT Life Sciences ’ EQT Health Economics 3 Fund (EQT HE3), a multi-stage life sciences and medtech-dedicated fund has received €25 million from the British Business Bank. EQT Life Sciences backs companies focused on the development of therapeutics, medical devices, diagnostics and healthtech. With a 30-year track record, the firm has raised over €3.7 billion across 13 private funds and supported more than 150 companies from early clinical development through to commercialisation.